Emily C Zabor

19PUBLICATIONS
103CO-AUTHORS
Molecular targetsPredictive and prognostic markersData models, storage and indexingHaematological tumoursDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 20, 2026
A Seamless Phase I/II Design With Randomization for Biomarker-Guided Oncology Trials.

|Feb 05, 2026
The Impact of Immunotherapy on Incidence of Second Primary Malignancies: A Surrogate for Antitumor Surveillance Activation.

Bridget Adcock, Moaath K Mustafa Ali, Emily C Zabor

|Oct 01, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.

Amanda Nizam, Charles B Nguyen, Jinju Li

|Aug 07, 2025
Combining Missing Data Imputation and Internal Validation in Clinical Risk Prediction Models.

Junhui Mi, Rahul D Tendulkar, Sarah M C Sittenfeld

|Jul 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab.

Taylor R Brooks, Emily C Zabor, Yohanna B Bedelu

|Oct 28, 2023
Surveillance for Metastasis in High-Risk Uveal Melanoma Patients: Standard versus Enhanced Protocols.

Yağmur Seda Yeşiltaş, Emily C Zabor, Jacquelyn Wrenn

Pageof 4

Frequent Collaborators

2 joint publications

Wen Wee Ma

2 joint publications

Brian P Hobbs

2 joint publications

Alexander M Kaizer

1 joint publications

Halei C Benefield